Kapikian AZ - Search Results

1

Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis.

Pang XL, Joensuu J, Hoshino Y, Kapikian AZ, Vesikari T. Pang XL, et al. Among authors: kapikian az. J Clin Virol. 1999 Jun;13(1-2):9-16. doi: 10.1016/s1386-6532(98)00013-4. J Clin Virol. 1999. PMID: 10405887 Clinical Trial.

2

Neonatal administration of rhesus rotavirus tetravalent vaccine.

Vesikari T, Karvonen A, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ. Vesikari T, et al. Among authors: kapikian az. Pediatr Infect Dis J. 2006 Feb;25(2):118-22. doi: 10.1097/01.inf.0000199288.98370.71. Pediatr Infect Dis J. 2006. PMID: 16462287 Clinical Trial.

3

Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.

Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, Kohberger R, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ. Vesikari T, et al. Among authors: kapikian az. J Infect Dis. 2006 Aug 1;194(3):370-6. doi: 10.1086/505151. Epub 2006 Jun 23. J Infect Dis. 2006. PMID: 16826486 Clinical Trial.

4

Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.

Vesikari T, Ruuska T, Green KY, Flores J, Kapikian AZ. Vesikari T, et al. Among authors: kapikian az. Pediatr Infect Dis J. 1992 Jul;11(7):535-42. doi: 10.1097/00006454-199207000-00006. Pediatr Infect Dis J. 1992. PMID: 1326741 Clinical Trial.

5

Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.

Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ. Vesikari T, et al. Among authors: kapikian az. Am J Dis Child. 1990 Mar;144(3):285-9. Am J Dis Child. 1990. PMID: 2154925 Clinical Trial.

6

Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.

Vesikari T, Varis T, Green K, Flores J, Kapikian AZ. Vesikari T, et al. Among authors: kapikian az. Vaccine. 1991 May;9(5):334-9. doi: 10.1016/0264-410x(91)90060-j. Vaccine. 1991. PMID: 1651610 Clinical Trial.

7

Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants.

Vesikari T, Ruuska T, Koivu HP, Green KY, Flores J, Kapikian AZ. Vesikari T, et al. Among authors: kapikian az. Pediatr Infect Dis J. 1991 Dec;10(12):912-7. doi: 10.1097/00006454-199112000-00006. Pediatr Infect Dis J. 1991. PMID: 1662796 Clinical Trial.

8

Reassortant rotaviruses as potential live rotavirus vaccine candidates.

Midthun K, Greenberg HB, Hoshino Y, Kapikian AZ, Wyatt RG, Chanock RM. Midthun K, et al. Among authors: kapikian az. J Virol. 1985 Mar;53(3):949-54. doi: 10.1128/JVI.53.3.949-954.1985. J Virol. 1985. PMID: 2983101 Free PMC article.

9

Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model.

Hoshino Y, Saif LJ, Kang SY, Sereno MM, Chen WK, Kapikian AZ. Hoshino Y, et al. Among authors: kapikian az. Virology. 1995 May 10;209(1):274-80. doi: 10.1006/viro.1995.1255. Virology. 1995. PMID: 7747480 Free article.

10

Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro.

Hoshino Y, Kapikian AZ, Chanock RM. Hoshino Y, et al. Among authors: kapikian az. J Virol. 1994 Nov;68(11):7598-602. doi: 10.1128/JVI.68.11.7598-7602.1994. J Virol. 1994. PMID: 7933149 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters